A retrospective hospital study found new benzodiazepine dispensing after discharge and subsequent repeat dispensing. Its operational definition did not establish daily consumption or a substance use disorder.
How persistence was defined
Love and colleagues examined 54,844 eligible internal-medicine admissions in Iceland between 2010 and 2020. Previously benzodiazepine-naive patients were classified as new users after a prescription fill within ninety days of discharge. A further fill between ninety and 180 days defined new persistent use.
New use followed 6.3% of admissions; 39.4% of those initiators met the repeat-fill definition. Sex, service specialty, and certain clinical characteristics were associated with the prescribing patterns.
The definition has boundaries
A second fill months later could reflect intermittent use, and a patient filling several prescriptions earlier might not meet the persistence rule. The investigators lacked indications and could not establish adherence from dispensing.
Differences among specialties may reflect symptom burden, patient selection, discharge practices, or prescribing culture. The retrospective design cannot identify which explanation caused the observed variation.
Why the distinction matters
Describe the result as post-discharge dispensing under the study’s specified windows. Do not turn it into a claim that nearly forty percent developed addiction or took a daily dose for six months. Individual exposure and dependence require their own clinical and medication evidence.
Source paper
Original analysis of the supplied journal article, identified as PMC13249842.
Leave a Reply